Use of eCommons for rapid dissemination of COVID-19 research
In order to maximize the discoverability of COVID-19 research, and to conform with repository best practices and the requirements of publishers and research funders, we provide special guidance for COVID-19 submissions.
Benign splenic hematoma : a retrospective study of a controversial diagnosis
|dc.description.abstract||Splenic hematoma with associated nodular hyperplasia is one of the most common causes of benign splenomegaly in the dog. Due to the unique architecture and function of the spleen, splenic tumors are very often associated with hematoma formation. This has made diagnoses of splenic hematoma a controversial topic in veterinary medicine. It is considered prudent to advise owners of the potential for a misdiagnosis due to the presence of hematomas admixed with neoplastic cells. Hemangiosarcoma is the most common splenic neoplasm and is characterized by poor survival rates and metastasis. This paper will focus on a case presentation of benign splenic hematoma and a retrospective study performed at Cornell investigating the survival times of animals with diagnosed benign hematomas over a period of ten years. Data compiled from previous retrospective studies will be presented in order to provide information pertaining to signalment, prognostic indicators and diagnostic methods for benign splenic hematoma and hemangiosarcoma in dogs.|
|dc.relation.ispartofseries||Senior seminar paper||en_US|
|dc.relation.ispartofseries||Seminar SF610.1 2007 L67||en_US|
|dc.subject||Dogs -- Diseases -- Diagnosis -- Case studies||en_US|
|dc.title||Benign splenic hematoma : a retrospective study of a controversial diagnosis||en_US|